X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23413) 23413
Publication (2164) 2164
Newspaper Article (2107) 2107
Newsletter (1161) 1161
Book Review (456) 456
Book Chapter (234) 234
Trade Publication Article (131) 131
Web Resource (110) 110
Book / eBook (91) 91
Transcript (54) 54
Magazine Article (52) 52
Conference Proceeding (28) 28
Dissertation (13) 13
Data Set (4) 4
Government Document (1) 1
Paper (1) 1
Reference (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18401) 18401
index medicus (11954) 11954
lymphomas (9555) 9555
oncology (9434) 9434
male (9217) 9217
female (8868) 8868
hematology (8135) 8135
cancer (7107) 7107
middle aged (6488) 6488
adult (6114) 6114
chemotherapy (5679) 5679
aged (4841) 4841
lymphoma (4800) 4800
leukemia (4069) 4069
care and treatment (4023) 4023
antineoplastic combined chemotherapy protocols - therapeutic use (3498) 3498
treatment outcome (3354) 3354
animals (3145) 3145
research (3094) 3094
non-hodgkin's lymphomas (3072) 3072
adolescent (2967) 2967
non-hodgkins-lymphoma (2918) 2918
t cells (2869) 2869
transplantation (2857) 2857
prognosis (2753) 2753
child (2503) 2503
health aspects (2439) 2439
therapy (2359) 2359
rituximab (2296) 2296
antineoplastic agents - therapeutic use (2279) 2279
apoptosis (2265) 2265
immunology (2196) 2196
medicine & public health (2118) 2118
stem cells (2106) 2106
analysis (2073) 2073
patients (2052) 2052
drug therapy (2028) 2028
tumors (1941) 1941
clinical trials (1870) 1870
aged, 80 and over (1666) 1666
lymphocytes (1655) 1655
diagnosis (1652) 1652
disease (1640) 1640
retrospective studies (1637) 1637
child, preschool (1636) 1636
expression (1633) 1633
immunotherapy (1617) 1617
risk factors (1576) 1576
cancer therapies (1545) 1545
mice (1533) 1533
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1510) 1510
hemic and lymphatic diseases (1503) 1503
young adult (1474) 1474
medical research (1470) 1470
b-cell lymphoma (1441) 1441
chronic lymphocytic-leukemia (1365) 1365
bone marrow (1357) 1357
survival (1356) 1356
genetic aspects (1334) 1334
children (1310) 1310
cell line, tumor (1307) 1307
article (1286) 1286
hematology, oncology and palliative medicine (1264) 1264
proteins (1257) 1257
disease-free survival (1255) 1255
pharmacology & pharmacy (1250) 1250
gene expression (1222) 1222
recurrence (1202) 1202
pathology (1198) 1198
pediatrics (1198) 1198
acute lymphoblastic-leukemia (1197) 1197
combined modality therapy (1193) 1193
remission induction (1179) 1179
medicine (1165) 1165
t-cell lymphoma (1155) 1155
antineoplastic combined chemotherapy protocols - administration & dosage (1093) 1093
lymphoma, non-hodgkin - drug therapy (1083) 1083
antineoplastic agents (1079) 1079
development and progression (1074) 1074
cyclophosphamide - administration & dosage (1057) 1057
antibodies, monoclonal - therapeutic use (1048) 1048
acute myeloid-leukemia (1035) 1035
multiple myeloma (1030) 1030
antimitotic agents (1014) 1014
hematopoietic stem cells (1009) 1009
medical prognosis (1009) 1009
infant (1008) 1008
follow-up studies (1001) 1001
cell biology (992) 992
bone-marrow-transplantation (991) 991
dermatology (977) 977
survival analysis (976) 976
antineoplastic combined chemotherapy protocols - adverse effects (975) 975
pharmaceutical industry (958) 958
hematopoietic stem cell transplantation (954) 954
antineoplastic agents - pharmacology (951) 951
flow cytometry (945) 945
mutation (942) 942
drug dosages (923) 923
medicine, research & experimental (918) 918
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (62) 62
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
UTL at Downsview - May be requested (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27099) 27099
Japanese (83) 83
Chinese (52) 52
German (20) 20
French (19) 19
Polish (13) 13
Russian (9) 9
Spanish (9) 9
Portuguese (8) 8
Korean (3) 3
Dutch (2) 2
Hungarian (2) 2
Turkish (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 11, pp. 1157 - 1163
Journal Article
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2015, Volume 168, Issue 6, pp. 811 - 819
Summary Belinostat is a pan‐histone deacetylase inhibitor with antitumour and anti‐angiogenic properties. An open label, multicentre study was conducted in... 
belinostat | peripheral T cell Lymphoma | mycosis fungoides | T cell lymphoma | histone deacetylase inhibitors | Mycosis fungoides | Peripheral T cell Lymphoma | Histone deacetylase inhibitors | Belinostat | HISTONE DEACETYLASE INHIBITOR | MULTICENTER | CARBOPLATIN | RESPONSE CRITERIA | CLINICAL-TRIAL | SOLID TUMORS | NON-HODGKINS-LYMPHOMAS | CLASSIFICATION | VORINOSTAT | BEXAROTENE | HEMATOLOGY | Recurrence | Humans | Hydroxamic Acids - adverse effects | Middle Aged | Histone Deacetylase Inhibitors - administration & dosage | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Lymphoma, T-Cell, Cutaneous - drug therapy | Young Adult | Antineoplastic Agents - adverse effects | Aged, 80 and over | Hydroxamic Acids - administration & dosage | Adult | Female | Lymphoma, T-Cell, Peripheral - drug therapy | Drug Administration Schedule | Treatment Outcome | Lymphoma, T-Cell, Cutaneous - pathology | Sulfonamides - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Sulfonamides - adverse effects | Hydroxamic Acids - therapeutic use | Aged | Histone Deacetylase Inhibitors - therapeutic use | Infusions, Intravenous | Neoplasm Staging | Histone Deacetylase Inhibitors - adverse effects | Sulfonamides - administration & dosage | Antimitotic agents | Care and treatment | Relapse | Clinical trials | Skin | Non-Hodgkin's lymphomas | Antineoplastic agents | T cells | Diseases
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2015, Volume 33, Issue 23, pp. 2492 - 2499
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 104 - 110
Journal Article